541096 — Bharat Parenterals Balance Sheet
0.000.00%
- IN₹8.33bn
- IN₹9.53bn
- IN₹3.40bn
- 30
- 12
- 54
- 19
Annual balance sheet for Bharat Parenterals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 468 | 349 | 89.3 | 109 | 589 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 762 | 806 | 1,289 | 1,791 | 2,105 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,480 | 1,437 | 1,843 | 2,599 | 3,555 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 438 | 654 | 1,402 | 2,334 | 2,291 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,986 | 2,261 | 3,503 | 5,038 | 6,485 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 436 | 415 | 1,198 | 1,904 | 2,193 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 548 | 602 | 1,675 | 3,066 | 3,179 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 1,439 | 1,658 | 1,828 | 1,973 | 3,307 |
| Total Liabilities & Shareholders' Equity | 1,986 | 2,261 | 3,503 | 5,038 | 6,485 |
| Total Common Shares Outstanding |